AbbVie
ABBV
ABBV
1,650 hedge funds and large institutions have $80.1B invested in AbbVie in 2015 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 681 increasing their positions, 634 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
5.4% more ownership
Funds ownership: 69.93% → 75.33% (+5.4%)
3% more funds holding
Funds holding: 1,598 → 1,650 (+52)
7% more repeat investments, than reductions
Existing positions increased: 681 | Existing positions reduced: 634
Holders
1,650
Holding in Top 10
142
Calls
$1.49B
Puts
$1.21B
Top Buyers
| 1 | +$2B | |
| 2 | +$1.04B | |
| 3 | +$966M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$679M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$577M |
Top Sellers
| 1 | -$503M | |
| 2 | -$303M | |
| 3 | -$267M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$248M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$219M |